4 chapters across the catalog
The FDA has authorized a new version of the Novavax vaccine targeting the JN1 strain, which has become the dominant seasonal variant. Health officials compare the current state of COVID-19 to the common cold, noting that the virus continues to mutate but at a more stable rate than the flu. Additionally, a new Moderna vaccine named "M Nex Spike" has received approval as the pharmaceutical industry continues its booster strategy.
The FDA granted emergency use authorization to the Novavax COVID-19 vaccine for adults, providing a protein-based alternative to mRNA options. While some individuals have waited for this specific technology to avoid mRNA, the hosts express skepticism regarding the company's history and the timing of the release.
The FDA is evaluating the Novavax vaccine following reports of myocarditis and pericarditis in other countries. Unlike the Pfizer and Moderna vaccines, Novavax is a non-mRNA option. Additionally, an Israeli study is mentioned linking COVID-19 vaccines to a 25% increase in cardiac arrests among young people.
Novavax Placebo Passports and Rand Paul Newsmax Gaffe
The UK Parliament confirmed that participants in the Novavax clinical trials will receive vaccine passports regardless of whether they received the active vaccine or a placebo. In a separate media event, a Newsmax anchor erroneously claimed that COVID-19 vaccines are not FDA-approved for senior citizens during an interview with Senator Rand Paul. The segment also highlighted the frequent verbal confusion between the terms "virus" and "vaccine" in broadcast media.
